in Industry News, News
Leidos, Immunovaccine Expand Malaria Vaccine Devt Partnership
Leidos and biopharmaceutical company Immunovaccine have expanded a partnership to develop peptide-based vaccines against malaria. The U.S. Agency for International Development and Leidos selected a vaccine delivery formulation based on Immunovaccine’s DepoVax platform for further research and development through a contract extension, Immunovaccine said Tuesday. USAID issued the new contract after the two companies completed various milestones under the Leidos […] More